Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Corcept Therapeutics
CORT
$12B
| $1.61M | ﹤0.01% |
73,135
-106,929
| -59% | -$2.38M |
|
|
SAGE
2327
DELISTED
Sage Therapeutics
SAGE
| $1.61M | ﹤0.01% |
28,310
-36,222
| -56% | -$2.56M |
|
2328
FLEX LNG
FLNG
$1.67B
| $1.61M | ﹤0.01% |
109,017
+86,907
| +393% | +$1.11M |
|
2329
Walker & Dunlop
WD
$1.53B
| $1.61M | ﹤0.01% |
15,401
-20,525
| -57% | -$2.15M |
|
2330
America's Car Mart
CRMT
$26.9M
| $1.6M | ﹤0.01% |
11,329
-874
| -7% | -$131K |
|
2331
PUT
AngloGold Ashanti
AU
$48.7B
| $1.6M | ﹤0.01% |
86,000
| – | – |
|
|
GRFS
2332
Grifois
GRFS
$5.4B
| $1.6M | ﹤0.01% |
91,960
-38,570
| -30% | -$691K |
|
|
KIN
2333
DELISTED
Kindred Biosciences, Inc.
KIN
| $1.6M | ﹤0.01% |
174,042
+142,896
| +459% | +$831K |
|
2334
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $1.59M | ﹤0.01% |
340,760
-300
| -0.1% | -$1.35K |
|
2335
Forward Air
FWRD
$654M
| $1.59M | ﹤0.01% |
17,702
-18,277
| -51% | -$1.68M |
|
2336
VanEck High Yield Muni ETF
HYD
$4.45B
| $1.58M | ﹤0.01% |
+24,900
| New | +$1.56M |
|
2337
Dorman Products
DORM
$4.18B
| $1.58M | ﹤0.01% |
15,259
-26,947
| -64% | -$2.76M |
|
2338
S&T Bancorp
STBA
$1.79B
| $1.57M | ﹤0.01% |
50,310
-10,814
| -18% | -$358K |
|
2339
Winnebago Industries
WGO
$909M
| $1.57M | ﹤0.01% |
23,134
-21,925
| -49% | -$1.62M |
|
2340
AerCap
AER
$23.8B
| $1.57M | ﹤0.01% |
30,663
+2,146
| +8% | +$124K |
|
2341
Belden
BDC
$5.19B
| $1.57M | ﹤0.01% |
31,028
-11,993
| -28% | -$586K |
|
2342
CALL
WIX.com
WIX
$2.52B
| $1.57M | ﹤0.01% |
5,400
| – | – |
|
2343
CALL
Clorox
CLX
$12.7B
| $1.56M | ﹤0.01% |
8,700
| – | – |
|
2344
Deluxe
DLX
$1.15B
| $1.56M | ﹤0.01% |
32,692
-24,170
| -43% | -$1.09M |
|
2345
United States Brent Oil Fund
BNO
$727M
| $1.56M | ﹤0.01% |
81,096
+10,593
| +15% | +$186K |
|
|
DVAX
2346
DELISTED
Dynavax Technologies
DVAX
| $1.56M | ﹤0.01% |
158,112
-231,354
| -59% | -$2.1M |
|
2347
Kura Oncology
KURA
$850M
| $1.56M | ﹤0.01% |
74,746
-61,456
| -45% | -$1.53M |
|
2348
United Natural Foods
UNFI
$2.85B
| $1.56M | ﹤0.01% |
42,144
-60,623
| -59% | -$2.2M |
|
2349
Virtus Investment Partners
VRTS
$1.1B
| $1.56M | ﹤0.01% |
5,606
-4,511
| -45% | -$1.22M |
|
|
PGTI
2350
DELISTED
PGT, Inc.
PGTI
| $1.56M | ﹤0.01% |
66,965
-38,443
| -36% | -$953K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.